Janssen sued Teva in the US District Court for the District of New Jersey under the Hatch-Waxman Act after Teva filed an abbreviated new drug application (ANDA) on a generic version of Invega Sustenna ...

Cidara to receive a $7 million milestone payment and is eligible to receive an additional $685 million in milestones, plus royalties As part of its exclusive worldwide collaboration with Janssen, ...

Sun Pharmaceutical Industries was hit with a patent infringement lawsuit on July 9 in New Jersey District Court over its attempt to market generic versions of the antipsychotic drug Invega Sustenna.

UTRECHT, The Netherlands & PHILADELPHIA--(BUSINESS WIRE)--Lava Therapeutics B.V., today announced that it has entered into a research and license agreement with Janssen Biotech, Inc., one of the ...

TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an ...

Millennium: The Takeda Oncology Company has announced that Takeda Pharmaceutcials Inc. has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for its cancer drug Velcade.

Pharma Mar SA (ES:PHM) has released an update. Pharma Mar S.A. has received a significant payment of $10 million from Janssen Products LP, a subsidiary of Johnson & Johnson, marking a commercial ...

Article ‘Count’ and ‘Share’ for Janssen-Cilag Pharma GmbH based on listed parameters only. The articles listed below published by authors from Janssen-Cilag Pharma GmbH, organized by journal and ...

SOUTH SAN FRANCISCO, Calif., and VANCOUVER, Canada, April 12, 2023 /PRNewswire/ - ESSA Pharma Inc. (EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the ...

A better understanding of early childhood microbiome shifts offers a unique window for detecting disease risk and intervening appropriately. In this webinar, Lloyd Bod and Nathaniel Robichaud will ...